Stocklytics Platform
Asset logo for symbol OCUL
Ocular Therapeutix
OCUL67
$8.39arrow_drop_down0.59%-$0.05
Asset logo for symbol OCUL
OCUL67

$8.39

arrow_drop_down0.59%

Performance History

Chart placeholder
Key Stats
Open$8.45
Prev. Close$8.44
EPS-1.09
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range8.13
8.53
52 Week Range1.99
11.31
Ratios
EPS-1.09

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Ocular Therapeutix (OCUL)

Ocular Therapeutix Inc (OCUL) is a biopharmaceutical company that develops and commercializes innovative therapies for diseases and conditions of the eye. With a focus on sustained release drug delivery technology, the company aims to improve the treatment options available to patients with various ocular disorders. Ocular Therapeutix was founded in 2006 and is headquartered in Bedford, Massachusetts.
The stock price history of Ocular Therapeutix Inc (OCUL) has seen significant fluctuations over the years. From its initial public offering (IPO) in 2014, the stock experienced a surge, reaching its all-time high of $59.81 in July 2015. However, subsequent years were challenging for the company, and the stock price declined steadily, hitting a low of $2.75 in November 2019. Since then, the stock has shown some recovery, but it is still far from its peak. As of the latest available data, the stock is trading at around $9.50.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Antony Mattessich
Headquarters
Bedford
Employees
274
Exchange
NASDAQ
add Ocular Therapeutix  to watchlist

Keep an eye on Ocular Therapeutix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Ocular Therapeutix 's (OCUL) price per share?

The current price per share for Ocular Therapeutix (OCUL) is $8.39. The stock has seen a price change of -$0.05 recently, indicating a -0.59% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Ocular Therapeutix (OCUL)?

For Ocular Therapeutix (OCUL), the 52-week high is $11.31, which is 34.8% from the current price. The 52-week low is $2, the current price is 320.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Ocular Therapeutix (OCUL) a growth stock?

Ocular Therapeutix (OCUL) has shown an average price growth of 0.41% over the past three years. It has received a score of 31 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ocular Therapeutix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Ocular Therapeutix (OCUL) stock price performance year to date (YTD)?

As of the latest data, Ocular Therapeutix (OCUL) has a year-to-date price change of 74.43%. Over the past month, the stock has experienced a price change of 6.34%. Over the last three months, the change has been 61.35%. Over the past six months, the figure is -22.53%. Looking at a longer horizon, the five-year price change stands at 91.55%.
help

Is Ocular Therapeutix (OCUL) a profitable company?

Ocular Therapeutix (OCUL) has a net income of -$80.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 90.96% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -265.13% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $58.44M, with a revenue growth rate of 13.49%, providing insight into the company's sales performance and growth. The gross profit is $53.16M. Operating income is noted at -$82.38M. Furthermore, the EBITDA is -$110.75M.
help

What is the market capitalization of Ocular Therapeutix (OCUL)?

Ocular Therapeutix (OCUL) has a market capitalization of $1.31B. The average daily trading volume is 639.38K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media